Literature DB >> 29511554

Suitability of the simplified autoimmune hepatitis score for the diagnosis of autoimmune hepatitis in a German cohort.

Hella Wobser1, Tanja Paur1, Elisabeth Schnoy1, Janine Hartl1, Gabriele I Kirchner1.   

Abstract

BACKGROUND: Several years ago the International Autoimmune Hepatitis Group simplified the previous revised original scoring system for diagnosis of autoimmune hepatitis (AIH) into a scoring system based on only four instead of 13 parameters.
OBJECTIVE: We aimed to evaluate the suitability of the simplified AIH score for diagnosis of AIH in a German cohort with chronic liver diseases.
METHODS: In this retrospective single-center study, we compared the accuracy of both AIH scores in 70 patients with AIH and 211 patients with chronic liver diseases (PBC (n = 52), PSC (n = 27), NASH (n = 67), DILI (n = 15), CHB/C (n = 50)). Sensitivity, specificity and predictability of each scoring system were calculated.
RESULTS: Using the simplified AIH score, the sensitivity and specificity of detecting a probable AIH (scores ≥ 6) were 96% and 97% with a positive and negative predictive value of 92% and 99%, respectively. For diagnosis of definite AIH (scores ≥ 7), the sensitivity and specificity were 43% and 100% with a positive and negative predictive value of 97% and 84%, respectively. The concordance with the revised original criteria was 63%. The specificity for excluding AIH was excellent in both scoring system.
CONCLUSION: The simplified diagnostic criteria allow a reliable diagnosis of AIH in a German cohort.

Entities:  

Keywords:  Autoimmune hepatitis (AIH); diagnostic scores; revised original criteria; routine clinical practice; simplified criteria

Year:  2017        PMID: 29511554      PMCID: PMC5833219          DOI: 10.1177/2050640617711632

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  34 in total

1.  American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease.

Authors: 
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Diagnosis and management of autoimmune hepatitis.

Authors:  Michael P Manns; Albert J Czaja; James D Gorham; Edward L Krawitt; Giorgina Mieli-Vergani; Diego Vergani; John M Vierling
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

3.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

Review 4.  Autoimmune hepatitis.

Authors:  Ansgar W Lohse; Giorgina Mieli-Vergani
Journal:  J Hepatol       Date:  2010-12-15       Impact factor: 25.083

5.  Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients.

Authors:  Linda Muñoz-Espinosa; Gabriela Alarcon; Amanda Mercado-Moreira; Paula Cordero; Eloy Caballero; Victor Avalos; Gregorio Villarreal; Karla Senties; David Puente; Jorge Soto; Brenda Esqueda; Gina Campos; Manuel Martínez; Joel Jaquez; Angel Ramirez; Itzel Reyes; David Kershenobich; Aldo J Montano-Loza
Journal:  Autoimmunity       Date:  2011-08-30       Impact factor: 2.815

6.  The international autoimmune hepatitis score in chronic hepatitis C.

Authors:  R C Dickson; M J Gaffey; M B Ishitani; T P Roarty; C J Driscoll; S H Caldwell
Journal:  J Viral Hepat       Date:  1997-03       Impact factor: 3.728

7.  Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.

Authors:  William R Kessler; Oscar W Cummings; George Eckert; Naga Chalasani; Lawrence Lumeng; Paul Y Kwo
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

Review 8.  Drug-induced liver injury with autoimmune features.

Authors:  Andrew S deLemos; David M Foureau; Carl Jacobs; Will Ahrens; Mark W Russo; Herbert L Bonkovsky
Journal:  Semin Liver Dis       Date:  2014-05-31       Impact factor: 6.115

9.  Validation of scoring system for diagnosis of autoimmune hepatitis.

Authors:  A Czaja; H A Carpenter
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

10.  Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.

Authors:  S Heringlake; A Schütte; P Flemming; W Schmiegel; M P Manns; H L Tillmann
Journal:  Z Gastroenterol       Date:  2009-05-05       Impact factor: 2.000

View more
  5 in total

1.  Evaluation of Validity and Efficiency of Diagnostic Criteria in Autoimmune Hepatitis in Children.

Authors:  Mohammadhadi Imanieh; Nazanin Amin Farzaneh; Seyed Mohsen Dehghani; Maryam Gholami Shahrebabak; Samaneh Hamzelou Hosseinabadi
Journal:  Turk J Gastroenterol       Date:  2021-06       Impact factor: 1.852

2.  Diagnostic Value of a Modified Version of Wilson's Diagnostic Score in Pediatrics.

Authors:  S Sajedianfard; M Ataollahi; S M Dehghani
Journal:  Int J Organ Transplant Med       Date:  2020

3.  Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.

Authors:  Lucas H P Bernts; David E J Jones; Marleen M Kaatee; Ansgar W Lohse; Christoph Schramm; Ekkehard Sturm; Joost P H Drenth
Journal:  Orphanet J Rare Dis       Date:  2019-07-08       Impact factor: 4.123

Review 4.  Clinical management of autoimmune hepatitis.

Authors:  Simon Pape; Christoph Schramm; Tom Jg Gevers
Journal:  United European Gastroenterol J       Date:  2019-08-25       Impact factor: 4.623

5.  Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience.

Authors:  Simon Pape; Frederik Nevens; Chris Verslype; Caroline Mertens; Joost P H Drenth; Eric T T L Tjwa
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-06       Impact factor: 2.586

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.